Wei‐Chen Lee

2.1k total citations
63 papers, 1.5k citations indexed

About

Wei‐Chen Lee is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Wei‐Chen Lee has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hepatology, 30 papers in Surgery and 25 papers in Epidemiology. Recurrent topics in Wei‐Chen Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Wei‐Chen Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Wei‐Chen Lee collaborates with scholars based in Taiwan, United States and United Kingdom. Wei‐Chen Lee's co-authors include Miin‐Fu Chen, Chun‐Nan Yeh, Kun‐Ming Chan, Ming‐Chin Yu, Chen‐Fang Lee, Long‐Bin Jeng, Ting-Jung Wu, Hong‐Shiue Chou, Huichuan Wang and Chien‐Fu Hung and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Wei‐Chen Lee

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei‐Chen Lee Taiwan	20	1.0k	551	524	433	290	63	1.5k
Kun‐Ming Chan Taiwan	26	1.1k 1.1×	899 1.6×	551 1.1×	461 1.1×	179 0.6×	118	1.8k
Chung‐Mau Lo Hong Kong	16	932 0.9×	565 1.0×	517 1.0×	310 0.7×	295 1.0×	25	1.5k
Martha M. Kirstein Germany	19	496 0.5×	423 0.8×	345 0.7×	384 0.9×	157 0.5×	65	1.2k
Ana Matilla Spain	21	1.4k 1.4×	475 0.9×	902 1.7×	463 1.1×	118 0.4×	52	1.7k
Gianludovico Rapaccini Italy	15	1.1k 1.1×	260 0.5×	1.0k 1.9×	168 0.4×	176 0.6×	23	1.5k
Hélène Voitot France	16	965 1.0×	675 1.2×	1.2k 2.2×	622 1.4×	193 0.7×	27	2.0k
Takeshi Nagao Japan	16	639 0.6×	419 0.8×	280 0.5×	241 0.6×	149 0.5×	64	1.3k
Kwong‐Ming Kee Taiwan	25	1.3k 1.3×	251 0.5×	1.1k 2.0×	188 0.4×	188 0.6×	87	1.6k
Maria Anna Di Nolfo Italy	19	1.6k 1.6×	323 0.6×	1.3k 2.6×	245 0.6×	264 0.9×	28	1.9k

Countries citing papers authored by Wei‐Chen Lee

Since Specialization

Citations

This map shows the geographic impact of Wei‐Chen Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chen Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chen Lee more than expected).

Fields of papers citing papers by Wei‐Chen Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chen Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chen Lee. The network helps show where Wei‐Chen Lee may publish in the future.

Co-authorship network of co-authors of Wei‐Chen Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chen Lee. A scholar is included among the top collaborators of Wei‐Chen Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chen Lee. Wei‐Chen Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wei‐Ting, Shi‐Ming Lin, Wei‐Chen Lee, et al.. (2022). GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology International. 16(1). 148–158. 11 indexed citations

Cheng, Chih‐Hsien, Yu-Chao Wang, Tsung‐Han Wu, et al.. (2022). Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma. Frontiers in Surgery. 9. 926728–926728. 3 indexed citations

Wang, Yu-Chao, Tsung‐Han Wu, Chen‐Fang Lee, et al.. (2021). Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment. World Journal of Surgical Oncology. 19(1). 313–313. 7 indexed citations

Lee, Chao‐Wei, Hsin‐I Tsai, Wei‐Chen Lee, et al.. (2019). Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?. Journal of Clinical Medicine. 8(10). 1736–1736. 49 indexed citations

Huang, Ya‐Hui, Kwang‐Huei Lin, Jau‐Song Yu, et al.. (2018). Targeting HSP60 by subcutaneous injections of jetPEI/HSP60‐shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth. Molecular Carcinogenesis. 57(9). 1087–1101. 15 indexed citations

Chu, Yu‐De, Kwang‐Huei Lin, Ya‐Hui Huang, et al.. (2018). A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib. Asia-Pacific Journal of Clinical Oncology. 14(5). e341–e351. 8 indexed citations

Chang, Chih‐Hsiang, Wei‐Ting Chen, Ming‐Hung Tsai, et al.. (2018). Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: A single-center retrospective study. Transfusion and Apheresis Science. 57(4). 537–543. 15 indexed citations

Weng, Li‐Chueh, et al.. (2017). Predictors of decision ambivalence and the differences between actual living liver donors and potential living liver donors. PLoS ONE. 12(5). e0175672–e0175672. 4 indexed citations

Yu, Ming‐Chin, Chao‐Wei Lee, Hsin‐I Tsai, et al.. (2017). RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer. 17(1). 742–742. 22 indexed citations

10.

Pan, Heng‐Chih, Ying-Jen Chen, Chang‐Chyi Jenq, et al.. (2016). Proteinuria can predict prognosis after liver transplantation. BMC Surgery. 16(1). 63–63. 10 indexed citations

11.

Lee, Chao‐Wei, Hsin‐I Tsai, Chun-Wei Chen, et al.. (2016). Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine. 95(39). e5028–e5028. 28 indexed citations

12.

Lee, Chen‐Fang, Wei‐Chen Lee, Ren‐Chin Wu, & Tse‐Ching Chen. (2016). Intrahepatic Duct Stones Harboring Ascariasis Ova. Medicine. 95(12). e3139–e3139. 4 indexed citations

13.

Wu, Sheng‐Mao, Tsung‐Han Wu, Ting‐Jung Wu, et al.. (2012). Liver resection for complicated hepatocellular carcinoma: Challenges but opportunity for long‐term survivals. Journal of Surgical Oncology. 106(8). 959–965. 17 indexed citations

14.

Lee, Chao‐Wei, Kun‐Ming Chan, Chen‐Fang Lee, et al.. (2011). Hepatic Resection for Hepatocellular Carcinoma With Lymph Node Metastasis: Clinicopathological Analysis and Survival Outcome. Asian Journal of Surgery. 34(2). 53–62. 38 indexed citations

15.

Chan, Kun‐Ming, Ming‐Chin Yu, Ting-Jung Wu, et al.. (2009). Efficacy of surgical resection in management of isolatedextrahepatic metastases of hepatocellular carcinoma. World Journal of Gastroenterology. 15(43). 5481–5481. 56 indexed citations

16.

Dahiya, Divya, et al.. (2009). Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: A 20-year experience. Surgery. 147(5). 676–685. 114 indexed citations

17.

Gautam, Anand M., Elizabeth A. Wilson, Pei‐Jer Chen, et al.. (2007). PI-88, a novel heparanase inhibitor, as adjuvant therapy for hepatocellular carcinoma: A large randomized phase II clinical trial. Cancer Research. 67. 2650–2650. 3 indexed citations

18.

Lee, Wei‐Chen & Miin‐Fu Chen. (2005). Assessment of hepatic reserve for indication of hepatic resection: how I do it. Journal of Hepato-Biliary-Pancreatic Surgery. 12(1). 23–26. 14 indexed citations

19.

Lee, Wei‐Chen, et al.. (2005). Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells. Journal of Immunotherapy. 28(5). 496–504. 152 indexed citations

20.

Yeh, Chun‐Nan, Wei‐Chen Lee, & Miin‐Fu Chen. (2003). Hepatic Resection and Prognosis for Patients With Hepatocellular Carcinoma Larger Than 10 cm: Two Decades of Experience at Chang Gung Memorial Hospital. Annals of Surgical Oncology. 10(9). 1070–1076. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact